Literature DB >> 12612259

Medical treatment of recurrent intussusception associated with intestinal lymphoid hyperplasia.

Eyal Shteyer1, Benjamin Z Koplewitz, Eitan Gross, Esther Granot.   

Abstract

Intestinal lymphoid hyperplasia (ILH) is an uncommon cause of recurrent intussusception in infants and young children. Surgical treatment has been suggested in the management of this disorder. We report 2 cases in which recurrent intussusception was associated with ILH. A short course of steroids resulted in resolution of both symptoms and hyperplasia. We conclude that when recurrent intussusception occurs in association with ILH, and no other lead point can be identified, it is important that treatment with steroids is considered before resorting to a more radical surgical approach.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12612259     DOI: 10.1542/peds.111.3.682

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  3 in total

1.  Chronic intussusception in children caused by Ascaris lumbricoides.

Authors:  Harry Nikolić; Goran Palčevski; Giordano Saina; Mladen Peršić
Journal:  Wien Klin Wochenschr       Date:  2011-04-19       Impact factor: 1.704

2.  Surgical treatment of recurrent intussusception induced by intestinal lymphoid hyperplasia in a child: is bowel resection always necessary? A case report.

Authors:  Hui Wang; Hongyan Li; Wang Xin; Liandi Xu; Guoqing Zhang; Qingtao Yan
Journal:  BMC Surg       Date:  2022-05-10       Impact factor: 2.030

3.  MIRAGE Syndrome Caused by a De Novo c.3406G>C (p. Glu1136Gln) Mutation in the SAMD9 Gene Presenting With Neonatal Adrenal Insufficiency and Recurrent Intussusception: A Case Report.

Authors:  Xinyi Chin; Aravind Venkatesh Sreedharan; Ene Choo Tan; Heming Wei; Jyn Ling Kuan; Christopher Wen Wei Ho; Joyce Ching Mei Lam; Teck Wah Ting; Rashida Farhad Vasanwala
Journal:  Front Endocrinol (Lausanne)       Date:  2021-09-29       Impact factor: 5.555

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.